Figure 4

The propagation of tumor delineation from the planning scans to the MP2RAGE output. (A) A \({T}_{1}\)-weighted scan taken after the administration of Gadovist and the CT scan it was then registered to for treatment planning purposes. (B) Both MPRAGE (\({T}_{1}\)-weighted) and MP2RAGE scans before and after the administration of AGuIX. In each instance, the tumor delineation was propagated from the planning scans to the research specific scans by image registration.